Winklevoss Asset Services has filed with the U.S. SEC to launch a spot Zcash ETF that would directly hold ZEC tokens and trade on Nasdaq under the ticker WINK. Gemini Trust Company will serve as the custodian for the ZEC assets. This ETF aims to allow investors to trade Zcash exposure without transferring the actual cryptocurrency, using a cash creation and redemption model. The filing awaits regulatory approval, while Zcash prices have recently risen ahead of an important network upgrade decision scheduled for October 20.
The Winklevoss spot Zcash ETF filing provides context for cryptocurrency market activity on Pluang. For readers following crypto assets, here is Pluang's market snapshot as of Oct 07, 2026 00:03 WIB: Among 50 major cryptocurrencies, 24 rose and 25 fell today. Notably, CRV (Curve DAO Token) declined by 2.87% to Rp6.503 with a typical hold time of 62 days and a Pluang order activity skewed 55% toward selling, contrasting with ONE (Harmony) which dropped 2.20% to Rp41 but saw a strong 82% buying interest and a longer typical hold time of 152 days.
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...
An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...
An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...
